Sorrento CEO, BioReference CEO And The Great Outdoors

As Sorrento Therapeutics gains FDA approval for phase two of their COVID-19 treatment, how should investors approach the stock? CEO Dr. Henry Ji checks in to discuss the company's latest developments against coronavirus after today's 20% gain. Then, BioReference Labs CEO Dr. Jon Cohen joins Cramer to talk about testing the NBA, major league soccer, and expanding testing throughout the U.S. as the pandemic continues. Plus, Cramer's revealing 4 stocks in the outdoor space that could be worth looking at.